Comparison of A140 and Erbitux Combined With mfolfox6 to Evaluate Efficacy and Safety of First-line Treatment for Ras Wild-type mCRC
Clinical trial NCT04835142 · COMPLETED
Trial details
- NCT number
- NCT04835142
- Sponsor
- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-31
- Primary completion
- 2023-03-22
- Enrollment
- 688
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.